authors
- Nair, Parameswaran Krishna
- Wenzel, SE
- Rabe, K-F
- Bourdm, A
- Lugogo, N
- Kuna, P
- Barker, P
- Sproule, S
- Ponnarambil, S
- Goldman, M
Benralizumab Significantly Reduced Oral Corticosteroid Dosages And Asthma Exacerbation Rates For Patients With Severe, Uncontrolled Asthma: Results Of The Zonda Phase Iii Trial
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- January 1, 2017
has subject area
- 11 Medical and Health Sciences (FoR)
- Respiratory System (Science Metrix)